REGEN BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $354.7K | — |
| FY2016 | — | $-255.9K | $24.8K |
| FY2017 | — | $-1.4M | $270.0K |
| FY2018 | — | $-8.5M | $8.0K |
| FY2019 | — | $-8.8M | $7.9K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $354.7K | — |
| FY2016 | — | $-255.9K | $24.8K |
| FY2017 | — | $-1.4M | $270.0K |
| FY2018 | — | $-8.5M | $8.0K |
| FY2019 | — | $-8.8M | $7.9K |